SGHT Insider Trading Activity and SEC Form 4 Filings
SGHT insider trading summary
Over the past 12 months, insiders at Sight Sciences, Inc. (SGHT) reported 38 sales worth $2.9M by 6 insiders and 2 open-market purchases worth $185K by 1 insider on SEC Form 4. Net insider selling was $2.7M.
Latest SGHT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 2, 2026 | James Rodberg | Chief Financial Officer | Sell | $64K (7,208 @ $8.85) |
| Oct 2, 2026 | Alison Bauerlein | Chief Operating Officer | Sell | $224K (25,260 @ $8.85) |
| Oct 2, 2026 | Brenton Taylor | EVP, Operations & R&D | Sell | $26K (2,988 @ $8.85) |
| Oct 1, 2026 | Paul Badawi | President and CEO | Sell | $268K (29,653 @ $9.05) |
| Oct 1, 2026 | David Badawi | Chief Technology Officer | Sell | $71K (7,797 @ $9.05) |
| Jul 6, 2026 | Jeremy B. Hayden | Chief Legal Officer | Sell | $70K (12,733 @ $5.51) |
| Jul 6, 2026 | David Badawi | Chief Technology Officer | Sell | $41K (7,418 @ $5.51) |
| Jul 2, 2026 | James Rodberg | Chief Financial Officer | Sell | $37K (6,902 @ $5.36) |
| Jul 2, 2026 | Alison Bauerlein | Chief Operating Officer | Sell | $130K (24,184 @ $5.36) |
| Jul 1, 2026 | Paul Badawi | President and CEO | Sell | $155K (28,684 @ $5.42) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.